Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-Free vs Opioid Anesthesia for Supratentorial Craniotomies
NCT04941040Phase 1Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Jul 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexmedetomidine, Lidocaine Hydrochloride Injection, without epinephrine, ketamine, magnesium sulfate, ketorolac and 1 more in supratentorial neoplasm (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Percentage of patients experiencing a change in mean arterial pressure at time of Burr Hole. Started Jul 2021; status: completed.
02
Drugs
dexmedetomidineLidocaine Hydrochloride Injection, without epinephrineketaminemagnesium sulfateketorolac
03
Conditions
supratentorial neoplasm
Beyond the preview
Go deeper on NCT04941040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04941040.